Jim Miller

Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

View Jim Miller's presentation from the AAPS 2009 Meeting and Exhibition.

A new analysis highlights growth drivers and challenges for clinical supply-chain services.

Contract organizations waiting for the pipeline to come roaring back are kidding themselves.

Apopular definition of insanity is repeating the same task over and over again while expecting a different result. It would appear, therefore, that many people in the contract services industry think the major global bio/pharma companies are insane.

Contract-service providers are expanding their offerings in this slow-growth environment.

A new analysis highlights growth drivers and challenges for clinical supply-chain services.

Contract-service providers are expanding their offerings in this slow-growth environment.

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.

In the current slow growth environment, service providers are looking to tactical expansions, as well as more ambitious strategic service expansions.

As the pharmaceutical industry looks to emerging markets, corruption becomes an important issue.

The contract services industry may not be as robust in 2009 as it has been in previous years, but it's not as bad as many people think.

A roundtable with pharma majors Pfizer and Johnson & Johnson, moderated by Jim Miller.

A Q&A with Pfizer CentreSource, moderated by Jim Miller.

Pharma companies that sell redundant facilities could endanger their supply chains.

A major CRO ventures further into proprietary drug development.

Pharma companies that sell redundant facilities could endanger their supply chains.

Despite the market downturn, private equity investors are lining up for pharmaceutical services.

A major CRO ventures further into proprietary drug development.

When the business environment returns to "normal," our industry may appear quite different.

Despite the market downturn, private equity investors are lining up for pharmaceutical services.

Dire circumstances are driving major drug companies to seek out CRO partners. This article contains bonus online-exclusive material.

When the business environment returns to "normal," our industry may appear quite different.

The financial crisis could lead to consolidation in the contract services industry.

Dire circumstances are driving major drug companies to seek out CRO partners. This article contains bonus online-exclusive material.

Early development spending has decreased sharply as industry responds to the financial crisis.

The financial crisis could lead to consolidation in the contract services industry.

Jim Miller's presentation at the 2008 AAPS Annual Meeting provides insight into outsourcing solutions.

Despite challenges, contract manufacturers in Europe are enjoying considerable success.

Early development spending has decreased sharply as industry responds to the financial crisis.